SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
19-Apr-24 5:20 PM View: | Ptc Therapeutics, Inc. (PTCT) | 17-Apr-24 | Sale | 787 | $25.14 | $19,781.20 | (1%) 68.48K to 67.69K | |
16-Feb-24 5:00 PM View: | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 24,300 | -- | -- | 55% 44.18K to 68.48K | |
01-Feb-24 4:16 PM View: | Ptc Therapeutics, Inc. (PTCT) | 30-Jan-24 | Sale | 366 | $27.25 | $9,973.79 | (< 1%) 44.55K to 44.18K | |
10-Jan-24 4:09 PM View: | Ptc Therapeutics, Inc. (PTCT) | 09-Jan-24 | Sale | 2,065 | $29.01 | $59,915.60 | (4%) 46.61K to 44.55K | |
10-Jan-24 4:09 PM View: | Ptc Therapeutics, Inc. (PTCT) | 08-Jan-24 | Sale | 1,569 | $28.64 | $44,936.60 | (3%) 48.18K to 46.61K | |
23-May-23 4:05 PM View: | Ptc Therapeutics, Inc. (PTCT) | 22-May-23 | Sale (Planned) | 2,013 | $59.01 | $118,791.00 | (4%) 49.57K to 47.55K | |
23-May-23 4:05 PM View: | Ptc Therapeutics, Inc. (PTCT) | 19-May-23 | Private Sale (Planned) | 6,403 | $58.96 | $377,491.00 | (11%) 55.97K to 49.57K | |
19-May-23 4:04 PM View: | Ptc Therapeutics, Inc. (PTCT) | 18-May-23 | Sale (Planned) | 788 | $58.71 | $46,266.90 | (1%) 56.76K to 55.97K | |
19-May-23 4:04 PM View: | Ptc Therapeutics, Inc. (PTCT) | 17-May-23 | Private Sale (Planned) | 8,048 | $58.50 | $470,822.00 | (12%) 64.81K to 56.76K | |
20-Apr-23 4:07 PM View: | Ptc Therapeutics, Inc. (PTCT) | 18-Apr-23 | Private Sale | 732 | $52.04 | $38,096.00 | (1%) 65.54K to 64.81K | |
02-Feb-23 4:21 PM View: | Ptc Therapeutics, Inc. (PTCT) | 31-Jan-23 | Private Sale | 375 | $45.63 | $17,110.50 | (< 1%) 65.91K to 65.54K | |
26-Jan-23 4:23 PM View: | Ptc Therapeutics, Inc. (PTCT) | 24-Jan-23 | Private Sale | 359 | $47.45 | $17,035.00 | (< 1%) 66.27K to 65.91K | |
12-Jan-23 4:35 PM View: | Ptc Therapeutics, Inc. (PTCT) | 11-Jan-23 | Private Sale | 571 | $44.36 | $25,329.30 | (< 1%) 66.84K to 66.27K | |
12-Jan-23 4:35 PM View: | Ptc Therapeutics, Inc. (PTCT) | 10-Jan-23 | Market Sale | 663 | $42.93 | $28,464.50 | (< 1%) 67.5K to 66.84K | 7% |
11-Jan-23 6:12 PM View: | Ptc Therapeutics, Inc. (PTCT) | 09-Jan-23 | Market Sale | 858 | $41.66 | $35,741.00 | (1%) 68.36K to 67.5K | 4% |
09-Jan-23 4:54 PM View: | Ptc Therapeutics, Inc. (PTCT) | 05-Jan-23 | Grant | 18,000 | -- | -- | 36% 50.36K to 68.36K | |
21-Apr-22 4:02 PM View: | Ptc Therapeutics, Inc. (PTCT) | 19-Apr-22 | Market Sale | 822 | $42.51 | $34,947.30 | (2%) 50.59K to 49.77K | 6% |
03-Feb-22 4:58 PM View: | Ptc Therapeutics, Inc. (PTCT) | 01-Feb-22 | Market Sale | 367 | $40.00 | $14,680.70 | (< 1%) 50.96K to 50.59K | (< 1%) |
27-Jan-22 4:02 PM View: | Ptc Therapeutics, Inc. (PTCT) | 25-Jan-22 | Market Sale | 359 | $39.31 | $14,113.70 | (< 1%) 51.32K to 50.96K | (2%) |
11-Jan-22 4:17 PM View: | Ptc Therapeutics, Inc. (PTCT) | 07-Jan-22 | Grant | 16,800 | -- | -- | 47% 35.39K to 52.19K | |
11-Jan-22 4:17 PM View: | Ptc Therapeutics, Inc. (PTCT) | 07-Jan-22 | Market Sale | 866 | $38.53 | $33,362.70 | (2%) 52.19K to 51.32K | |
06-Jan-22 4:09 PM View: | Ptc Therapeutics, Inc. (PTCT) | 04-Jan-22 | Market Sale | 806 | $41.16 | $33,176.60 | (2%) 36.19K to 35.39K | 7% |
21-Apr-21 4:12 PM View: | Ptc Therapeutics, Inc. (PTCT) | 19-Apr-21 | Market Sale | 786 | $48.17 | $37,860.00 | (2%) 36.49K to 35.7K | 4% |
02-Feb-21 6:21 PM View: | Ptc Therapeutics, Inc. (PTCT) | 01-Feb-21 | Market Sale | 362 | $56.96 | $20,618.10 | (< 1%) 36.85K to 36.49K | < 1% |
27-Jan-21 4:24 PM View: | Ptc Therapeutics, Inc. (PTCT) | 25-Jan-21 | Market Sale | 431 | $62.05 | $26,745.30 | (1%) 37.28K to 36.85K | 1% |
08-Jan-21 5:16 PM View: | Ptc Therapeutics, Inc. (PTCT) | 06-Jan-21 | Grant | 10,200 | -- | -- | 38% 27.08K to 37.28K | |
07-Jan-21 4:59 PM View: | Ptc Therapeutics, Inc. (PTCT) | 05-Jan-21 | Market Sale | 1,067 | $62.37 | $66,548.80 | (4%) 28.15K to 27.08K | (7%) |
05-Nov-20 4:25 PM View: | Ptc Therapeutics, Inc. (PTCT) | 03-Nov-20 | Market Sale (Planned) | 6,194 | $56.50 | $349,961.00 | (18%) 33.84K to 27.65K | |
17-Apr-20 4:26 PM View: | Ptc Therapeutics, Inc. (PTCT) | 16-Apr-20 | Grant | 10,000 | -- | -- | 42% 23.84K to 33.84K | |
24-Feb-15 9:15 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 21-Feb-15 | Disposition (change in control) | 30,029 | $46.00 | $1,381,330.00 | (100%) 30.03K to 0 | |
20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-15 | Payment of Exercise | 3,005 | $45.88 | $137,869.00 | (9%) 33.03K to 30.03K | |
20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-15 | Option Exercise | 8,100 | -- | -- | 32% 24.93K to 33.03K | |
20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 12-Feb-15 | Payment of Exercise | 957 | $45.85 | $43,878.40 | (4%) 25.89K to 24.93K | |
20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 12-Feb-15 | Option Exercise | 2,787 | -- | -- | 12% 23.1K to 25.89K | |
20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-15 | Payment of Exercise | 1,662 | $45.85 | $76,202.70 | (7%) 24.77K to 23.1K | |
20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-15 | Acquisition (other) | 4,867 | -- | -- | 24% 19.9K to 24.77K | |
30-Sep-14 11:17 AM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 26-Sep-14 | Payment of Exercise | 5,185 | $27.55 | $142,847.00 | (17%) 29.95K to 24.77K | 2% |
30-Sep-14 11:17 AM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 26-Sep-14 | Acquisition (other) | 10,000 | -- | -- | 50% 19.95K to 29.95K | |
05-Aug-14 4:18 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 01-Aug-14 | Payment of Exercise | 620 | $27.86 | $17,273.20 | (2%) 30.57K to 29.95K | 3% |
05-Aug-14 4:18 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 01-Aug-14 | Option Exercise | 1,667 | -- | -- | 6% 28.9K to 30.57K | |
14-Feb-14 8:28 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-14 | Payment of Exercise | 2,828 | $38.30 | $108,312.00 | (9%) 31.73K to 28.9K | 29% |
14-Feb-14 8:28 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-14 | Option Exercise | 8,100 | -- | -- | 34% 23.63K to 31.73K | |
11-Feb-14 4:22 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-14 | Payment of Exercise | 1,759 | $35.13 | $61,793.70 | (7%) 25.39K to 23.63K | 23% |
11-Feb-14 4:22 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-14 | Acquisition (other) | 4,867 | -- | -- | 24% 20.52K to 25.39K | |
11-Feb-13 4:47 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-13 | Payment of Exercise | 1,929 | $8.61 | $16,608.70 | (8%) 24.6K to 22.67K | (215%) |
11-Feb-13 4:47 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-13 | Acquisition (other) | 4,866 | -- | -- | 25% 19.73K to 24.6K | |
09-Feb-12 5:06 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-12 | Grant | 14,600 | -- | -- | 100% 0 to 14.6K | |
27-Sep-11 4:02 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 26-Sep-11 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
01-Mar-11 8:39 PM View: | Accuray Inc (ARAY) | 28-Feb-11 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K |